Top

International Ophthalmology

Published in:

01-08-2020 | Original Paper

Analysis of WWOX gene expression and protein levels in pterygium

Authors: Nihan Bozkurt, Omer Ates

Published in: International Ophthalmology | Issue 8/2020

Abstract

Purpose

Pterygium, a degenerative and hyperplastic lesion, has premalignant properties as a tumor analog. WWOX is a tumor suppressor gene and involved in many signal pathways, such as cell proliferation, embryonic development, metabolism and apoptosis. In many cancers, the loss of WWOX or the presence of abnormal transcripts indicates the tumor suppressor activity of WWOX. In this study, it was aimed to determine WWOX gene expression and protein levels in pterygium which may be a tumor analog.

Methods

For this purpose, the WWOX gene expression change in 27 pterygium tissue was investigated by real-time PCR method, and the change in WWOX protein was investigated using the Western blot method.

Results

According to our results, it was found that the expression and protein levels of WWOX gene in pterygium tissue decreased significantly compared to control tissue (p < 0.05).

Conclusion

This information indicates that a decrease in expression and protein level in pterygium tissue of WWOX, a tumor suppressor gene, supports claims that pterygium may be a cancer analog tissue.

Donald THT, Wen YT, Yan PL, Hak-Su G, Duncan RS (2000) Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 84:212–216CrossRef

Cárdenas-Cantú E, Zavala J, Valenzuela J, Valdez-García JE (2016) Molecular basis of pterygium development. Semin Ophthalmol 31(6):567–583PubMed

Liu T, Liu Y, Xie L, He X, Ji Bai J (2013) Progress in the pathogenesis of pterygium. Curr Eye Res 38(12):1191–1197PubMedCrossRef

Sebastiá R, Ventura MP, Solari HP, Antecka E, Orellana ME, Burnier MN (2013) Immunohistochemical detection of Hsp90 and Ki-67 in pterygium. Diagn Pathol 8:32PubMedPubMedCentralCrossRef

Demiryürek S, Saracaloglu A, Kimyon S, Mete A, Eronat O, Temiz E, Nacarkahya G, Tunca ZS, Düzen B, Saygili O, Güngör K, Karakök M, Demiryürek AT (2019) Increased expressions of ICAM-2 and ICAM-3 in pterygium. Curr Eye Res. https://doi.org/10.1080/02713683.2019.1570527 PubMedCrossRef

Liang K, Jiang Z, Ding B, Cheng P, Huang D, Tao L (2011) Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva. Mol Vis 17:1687–1693PubMedPubMedCentral

Girolamo ND, Chui J, Coroneo MT, Wakefield D (2004) Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 23:195–228PubMedCrossRef

Huang YH, Chang NS, Tseng SH (2015) Expression of WW domain-containing oxidoreductase WWOX in pterygium. Mol Vis 21:711–717PubMedPubMedCentral

Tung JN, Chiang CC, Tsai YY, Chou YY, Yeh KT, Lee H, Cheng YW (2010) CyclinD1 protein expressed in pterygia is associated with β-catenin protein localization. Mol Vis 16:2733–2738PubMedPubMedCentral

10.

Baryła I, Styczen-Binkowska E, Bednarek AK (2015) Alteration of WWOX in human cancer, a clinical view. Exp Biol Med 240:305–314CrossRef

11.

Schrock MS, Huebner K (2015) WWOX: a fragile tumor suppressor. Exp Biol Med 240:296–304CrossRef

12.

Yang Z, Lan H, Chen X, Li P, Li S, Mo W, Tang A (2014) Molecular alterations of the WWOX gene in nasopharyngeal carcinoma. Neoplasma 61(2):170–176PubMedCrossRef

13.

Lin JT, Li HY, Chang NS, Lin CH, Chen YC, Lu PJ (2015) WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase. Cell Cycle 14(3):408–416PubMedPubMedCentralCrossRef

14.

Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3(6):1101–1108PubMedCrossRef

15.

Adıguzel U, Karabacak T, Sarı A, Oz O, Cınel L (2007) Cyclooxygenase-2 expression in primary and recurrent pterygium. Eur J Ophthalmol 17(6):879–884PubMedCrossRef

16.

Spandidos DA, Sourvinos G, Kiaris H, Tsamparlakis J (1997) Microsatellite instability and loss of heterozygosity in human pterygia. Br J Ophthalmol 81:493–496PubMedPubMedCentralCrossRef

17.

Weinstein O, Rosenthal G, Zirkin H, Monos T, Lifshitz T, Argov S (2002) Overexpression of p53 tumor suppressor gene in pterygia. Eye 16:619–621PubMedCrossRef

18.

Wistuba II, Behrens C, Virmani AK (2000) High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 60:1949–1960PubMed

19.

Nowakowska M, Płuciennik E, Wujcicka W, Sitkiewicz A, Kazanowska B, Zielińska E, Bednarek AK (2014) The correlation analysis of WWOX expression and cancer related genes in neuroblastoma—a real time RT-PCR study. Acta Biochim Pol 61(1):91–97PubMedCrossRef

20.

Abdeen SK, David UB, Shweiki A, Maly B, Aqeilan RI (2018) Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer. Cell Death Dis 9:832PubMedPubMedCentralCrossRef

21.

Aldaz CM, Ferguson BW, Abba MC (1846) WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies. Biochim Biophys Acta 2014:188–200

22.

Płuciennik E, Nowakowska M, Wujcicka WI, Sitkiewicz A, Kazanowska B, Zielińska E, Bednarek AK (2012) Genetic alterations of WWOX in Wilms’ tumor are involved in its carcinogenesis. Oncol Rep 28(4):1417–1422PubMedCrossRef

23.

Qin HR, Iliopoulos D, Nakamura T, Costinean S, Volinia S, Druck T, Sun J, Okumura H, Huebner K (2007) Wwox suppresses prostate cancer cell growth through modulation of ErbB2-mediated androgen receptor signaling. Mol Cancer Res 5(9):957–965PubMedCrossRef

24.

Yang J, Zhang W (2008) WWOX tumor suppressor gene. Histol Histopathol 23:877–882PubMed

25.

Nunez MI, Ludes-Meyers J, Abba MC, Kil H, Abbey NW, Page RE, Sahin A, Klein-Szanto AJ, Aldaz CM (2005) Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status. Breast Cancer Res Treat 89:99–105PubMedPubMedCentralCrossRef

26.

Chang R, Song L, Xu Y, Wu Y, Dai C, Wang X, Sun X, Hou Y, Li W, Zhan X, Zhan L (2018) Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis. Nat Commun 9(1):3486PubMedPubMedCentralCrossRef

27.

Ekizoglu S, Bulut P, Karaman E, Kilic E, Buyru N (2015) Epigenetic and genetic alterations affect the WWOX gene in head and neck squamous cell carcinoma. PLoS ONE. https://doi.org/10.1371/journal.pone.0115353 PubMedPubMedCentralCrossRef

Title: Analysis of WWOX gene expression and protein levels in pterygium
Authors: Nihan Bozkurt
Omer Ates
Publication date: 01-08-2020
Publisher: Springer Netherlands
Published in: International Ophthalmology / Issue 8/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-020-01368-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Analysis of WWOX gene expression and protein levels in pterygium

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2020

Combined aspirin and clopidogrel therapy in phacoemulsification cataract surgery: a risk factor for ocular hemorrhage?

A comparison of three different tonometric methods in the measurement of intraocular pressure in the pediatric age group

Is there a relationship between hypoparathyroidism and retinal microcirculation?

The effect of topical tropicamide and phenylephrine on macular and peripapillary microvasculature: an optical coherence tomography angiography study

Recurrent retinal detachment after diabetic vitrectomy

Gonioscopy-assisted transluminal trabeculotomy as an option after failed trabeculectomy